5 April 2022
Clinical report of Arthrys double treatment on 20 patients
We are releasing a preliminary report of our Arthrys post-market clinical follow-up (PMCF) done in collaboration with Dr. Francesco Fiacchi, orthopaedic surgeon in Mantua (Suzzarra).
This PMCF activity enrolled patients with knee and hip osteoarthritis, treated with a first intra-articular injection of Arthrys 5mg/ml and a secondary shot of the same product at six months. We have assessed the safety and effectiveness of hydrolyzed collagen in ameliorating pain and functionality symptoms and its feasibility for re-treatment.
The report is available for direct download here or on Arthrys portfolio page.